Last quarter (Q4 2022), Immunocore Holdings's total revenue was £48.06M, an increase of 628.99% from the same quarter last year. In Q4, Immunocore Holdings's net income was £-25.20M. See Immunocore Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	£ 143.74M	£ 143.74M	£ 26.52M	£ 30.11M	£ 25.67M	£ 23.65M
Cost of Revenue	£ 454.00K	£ 454.00K	-	£ 0.00	-	-
Gross Profit	£ 143.28M	£ 143.28M	£ 26.52M	£ 30.11M	-	-
Operating Expense	£ 180.51M	£ 182.89M	£ 161.63M	£ 119.40M	£ 144.17M	£ 117.73M
Operating Income	£ -37.23M	£ -39.61M	£ -135.10M	£ -89.29M	£ -118.50M	£ -94.08M
Net Non Operating Interest Income Expense	£ -4.54M	£ -4.54M	£ -5.77M	£ -2.40M	£ -2.40M	£ -20.00K
Other Income Expense	£ -2.38M	£ -3.00K	£ 57.00K	£ 4.33M	£ -5.28M	£ 5.92M
Pretax Income	£ -44.15M	£ -44.15M	£ -140.93M	£ -87.36M	£ -126.19M	£ -88.18M
Tax Provision	£ -2.92M	£ -2.92M	£ -9.40M	£ -13.27M	£ -22.26M	£ -16.55M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	£ -41.22M	£ -41.22M	£ -131.52M	£ -74.09M	£ -103.93M	£ -71.63M
Basic EPS	£ -0.92	£ -0.90	£ -3.10	£ -2.33	£ >-0.01	£ >-0.01
Diluted EPS	£ -0.93	£ -0.90	£ -3.10	£ -2.33	£ >-0.01	£ >-0.01
Basic Average Shares	£ 182.83M	£ 45.71M	£ 42.49M	£ 31.78M	£ 22.30B	£ 27.31B
Diluted Average Shares	£ 187.27M	£ 45.71M	£ 42.49M	£ 31.78M	£ 22.30B	£ 27.31B
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	£ <0.01	£ <0.01
Reported Normalized Diluted E P S	-	-	-	-	£ <0.01	£ <0.01
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	£ 180.97M	£ 183.35M	-	£ 119.40M	£ 144.17M	£ 117.73M
Net Income From Continuing And Discontinued Operation	£ -41.22M	£ -41.22M	£ -131.52M	£ -74.09M	£ -103.93M	£ -71.63M
Normalized Income	£ -40.75M	£ -47.07M	£ -150.33M	£ -74.24M	£ -99.43M	£ -71.89M
Interest Expense	£ 6.30M	-	-	£ 3.11M	£ 3.80M	£ 842.00K
EBIT	£ -37.85M	£ -36.45M	£ -135.16M	£ -84.25M	£ -122.39M	£ -87.34M
EBITDA	£ -31.71M	£ -30.32M	-	£ -75.28M	£ -113.18M	£ -80.63M

Currency in GBP

Immunocore Holdings Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing